Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Goodwill (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Goodwill for 17 consecutive years, with $615.2 million as the latest value for Q4 2025.

  • Quarterly Goodwill fell 43.92% to $615.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $615.2 million through Dec 2025, down 43.92% year-over-year, with the annual reading at $615.2 million for FY2025, 43.92% down from the prior year.
  • Goodwill hit $615.2 million in Q4 2025 for Integra Lifesciences Holdings, roughly flat from $615.2 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $1.1 billion in Q3 2024 to a low of $94.1 million in Q2 2021.
  • Historically, Goodwill has averaged $931.6 million across 5 years, with a median of $1.0 billion in 2021.
  • Biggest five-year swings in Goodwill: plummeted 90.15% in 2021 and later skyrocketed 951.98% in 2022.
  • Year by year, Goodwill stood at $1.0 billion in 2021, then grew by 2.51% to $1.0 billion in 2022, then increased by 1.6% to $1.1 billion in 2023, then rose by 3.93% to $1.1 billion in 2024, then plummeted by 43.92% to $615.2 million in 2025.
  • Business Quant data shows Goodwill for IART at $615.2 million in Q4 2025, $615.2 million in Q3 2025, and $616.4 million in Q2 2025.